Dr. Greg Licholai, a biotech entrepreneur and a lecturer at Yale SOM, explains the gene-editing technology’s potential and its dangers.

Since Facebook's stock structure guarantees CEO Mark Zuckerberg control, Yale SOM’s Jeffrey Sonnenfeld writes, its only hope is some brutally honest feedback from his star-studded board.

The age of the video call has arrived, just as science fiction predicted. Scott Wharton ’95, who leads video collaboration at Logitech, talks about the potential of videoconferencing and the steps needed to make it ubiquitous.

Nonprofits compete too. Could technology offer a means to improve performance, innovate, and deliver on mission?

A change to European privacy rules has unleashed a flood of emails about updated privacy policies to customers all over the world. We asked Yale SOM’s David Bach why.

A statistical tool that predicts when patients with advanced cancer are likely to die could help promote patient welfare by transferring more people from aggressive interventions to hospice care.

What does the Facebook-Cambridge Analytica scandal say about the risks of trusting Facebook and other tech companies with our data? We talked with Yale Law School's Jack Balkin.

The CEO of Facebook is apologizing to Congress for the company’s misuse of user data. But real contrition, Yale SOM’s Jeffrey Sonnenfeld writes, means explaining what you did wrong and making sure it doesn’t happen again. 

Women inventors are less likely to have their patent applications approved than men. But that disparity dips if an examiner can’t guess an inventor’s gender from her name.

With legislators demanding answers from Facebook and users deleting the company's app, its top leaders have been silent. We asked Prof. Jeffrey Sonnenfeld how they should be responding to the Cambridge Analytica scandal.